RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology
RevBio Receives a $2 Million NIH Grant to Pursue the Treatment of Wrist Fractures with Its Innovative Bone Adhesive Technology This Grant will Fund the Completion of the Company's Pre-Clinical Research Paving the Way to Initiate a Clinical Study for this Indication. News provided by Share this article Share this article LOWELL, Mass., April 6, 2021 /PRNewswire/ -- RevBio, Inc., announced that it has been awarded a Phase II Small Business Innovation Research (SBIR) grant expected to total $2 million over two years from the National Institute on Aging, part of the National Institutes of Health....
Source: prnewswire.com